Key result
Cardiac diffusion MRI evaluates myocardial microstructure in HCM and IHD despite limited clinical validation.
Why the study?
Does cardiac diffusion MRI have potential for evaluating myocardial microstructure in hypertrophic cardiomyopathy and ischemic heart disease?
Does cardiac diffusion MRI have potential for evaluating myocardial microstructure in hypertrophic cardiomyopathy and ischemic heart disease?
Cardiac diffusion MRI shows promise for evaluating myocardial microstructure in hypertrophic cardiomyopathy and ischemic heart disease, but requires further validation before clinical adoption.
Answers are grounded in this paper and cite their sources.
Cardiac diffusion MRI may aid microstructural assessment in HCM and IHD; leaves open standardized validation before clinical adoption.
In a scoping review of 55 studies, cardiac diffusion MRI demonstrated the potential for evaluating myocardial microstructure in hypertrophic cardiomyopathy and ischemic heart disease, although clinical adoption remains limited by heterogeneity and limited validation.
No takes yet. Share an insight, caveat, or question.
Vora et al. (2026) studied this question. Cardiac diffusion MRI can evaluate myocardial microstructure in hypertrophic cardiomyopathy and ischemic heart disease, though clinical adoption is limited by heterogeneity and limited validation.
Synapse has enriched 10 related papers. Consider them for comparative context: